Evidence map›Paper›PMID 28130404›Full record

ArticleThe Journal of experimental medicine2017

Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection.

Claire L Gordon, Michelle Miron, Joseph J C Thome, Nobuhide Matsuoka, Joshua Weiner, Michael A Rak, Suzu Igarashi, Tomer Granot, Harvey Lerner, Felicia Goodrum and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 161 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Joining the dots: maternal cytomegalovirus, HIV and the placenta.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Claire L GordonColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032.
Michelle MironColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032.ORCID 0000-0002-2593-3857
Joseph J C ThomeColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032.
Nobuhide MatsuokaColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032.ORCID 0000-0002-1217-6842
Joshua WeinerColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032.ORCID 0000-0003-3780-1875
Michael A RakDepartment of Immunobiology, University of Arizona, Tucson, AZ 85721.ORCID 0000-0003-0010-7935
Suzu IgarashiDepartment of Immunobiology, University of Arizona, Tucson, AZ 85721.
Tomer GranotColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032.ORCID 0000-0003-2899-904X
Harvey LernerLiveOnNY, New York, NY 10001.ORCID 0000-0002-1857-5190
Felicia GoodrumDepartment of Immunobiology, University of Arizona, Tucson, AZ 85721.ORCID 0000-0002-6646-7290
Donna L FarberColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032 df2396@cumc.columbia.edu.ORCID 0000-0001-8236-9183
Columbia University Irving Medical Center · USUniversity of Arizona · US

Funding

Transcriptomics and Repertoire ProfilingP01AI106697 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Donna L. Farber · 2013 to 2026
$31.3M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
Mechanisms of Human Cytomegalovirus Latency in Primary Human Hematopoietic CellsR01AI079059 · NIAID · UNIVERSITY OF ARIZONA · PI GOODRUM, FELICIA D · 2008 to 2018
$4.4M
Mechanisms of Human Cytomegalovirus Latency in Primary Human Hematopoietic CellsR37AI079059 · NIAID · UNIVERSITY OF ARIZONA · PI Felicia D Goodrum · 2019 to 2026
$3.3M
Columbia University Graduate Training Program in Microbiology and ImmunologyT32AI106711 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Nicholas Arpaia, Uttiya Basu · 2014 to 2026
$2.1M
Lung resident niches for memory CD4 T cellsR01HL116136 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FARBER, DONNA L. · 2015 to 2018
$1.6M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
Longevity and turnover of human naive T cells in lymphoid tissueF31AG047003 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI THOME, JOSEPH JOHN-CHARLES · 2013 to 2015
$109k
NCATS NIH HHS UL1 TR000040NCRR NIH HHS S10 RR027050NHLBI NIH HHS R01 HL116136NIAID NIH HHS HHSN272201300006CNIAID NIH HHS P01 AI106697NIAID NIH HHS R37 AI079059NIAID NIH HHS T32 AI106711NIA NIH HHS F31 AG047003
6 · The paper itself

Abstract

T cell responses to viruses are initiated and maintained in tissue sites; however, knowledge of human antiviral T cells is largely derived from blood. Cytomegalovirus (CMV) persists in most humans, requires T cell immunity to control, yet tissue immune responses remain undefined. Here, we investigated human CMV-specific T cells, virus persistence and CMV-associated T cell homeostasis in blood, lymphoid, mucosal and secretory tissues of 44 CMV seropositive and 28 seronegative donors. CMV-specific T cells were maintained in distinct distribution patterns, highest in blood, bone marrow (BM), or lymph nodes (LN), with the frequency and function in blood distinct from tissues. CMV genomes were detected predominantly in lung and also in spleen, BM, blood and LN. High frequencies of activated CMV-specific T cells were found in blood and BM samples with low virus detection, whereas in lung, CMV-specific T cells were present along with detectable virus. In LNs, CMV-specific T cells exhibited quiescent phenotypes independent of virus. Overall, T cell differentiation was enhanced in sites of viral persistence with age. Together, our results suggest tissue T cell reservoirs for CMV control shaped by both viral and tissue-intrinsic factors, with global effects on homeostasis of tissue T cells over the lifespan.

Indexed as

CD8-Positive T-LymphocytesCytomegalovirusCytomegalovirus InfectionsHumansInterferon-gammaLymph NodesT-LymphocytesViremiaInterferon-gamma

Identifiers

PMID28130404
PMCPMC5339671
OpenAlexW2584361279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.